The incidence of hepatitis flare and hepatic decompensation after nucleos(t)ide analogue cessation in chronic hepatitis B patients

被引：0
|
作者：
Dongelmans, Edo J. [1 ]
Janssen, Harry L. A. [1 ,2 ]
机构：
[1] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
来源：
JOURNAL OF HEPATOLOGY | 2025年 / 82卷 / 04期
关键词：
D O I：
10.1016/j.jhep.2024.11.044
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：e174 / e175
页数：2
相关论文
共 50 条
  • [31] Keystone to Secure Safety After Stopping Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients Reply
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Nguyen, Mindie H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1891 - 1892
  • [32] Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
    Chang, M. -L.
    Liaw, Y. -F.
    Hadziyannis, S. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (03) : 243 - 257
  • [33] Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
    Jihye Lim
    Hyundam Gu
    Hyunji Sang
    Su Jin Jeong
    Ha Il Kim
    Alzheimer's Research & Therapy, 17 (1)
  • [34] Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
    Lee, Teng-Yu
    Hsu, Yao-Chun
    Yu, Shi-Hang
    Lin, Jaw-Town
    Wu, Ming-Shiang
    Wu, Chun-Ying
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 947 - +
  • [35] Nucleos(t)ide Analogue Treatment Cessation in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients: A Retrospective Single-center Study
    Sarigul, Figen
    User, Ulku
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2020, 9
  • [36] Eligibility for Nucleos(t)ide Analogue Treatment Disconti- nuation in Patients with Chronic Hepatitis B
    Dias, Joana Gomes
    Moradpour, Darius
    Mdawar-Bailly, Elise
    Fraga, Montserrat
    Barbosa, Joana Vieira
    SWISS MEDICAL WEEKLY, 2024, 154 : 36S - 37S
  • [37] The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy
    Coffin, C. S.
    Rezaeeaval, M.
    Pang, J. X.
    Alcantara, L.
    Klein, P.
    Burak, K. W.
    Myers, R. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) : 1262 - 1269
  • [38] Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients
    Ingiliz, P.
    Canbay, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (11) : 1551 - 1552
  • [39] Circulating hepatitis B virus RNA levels are associated with risk of hepatitis flare after stopping nucleos(t)ide analogue therapy in hepatitis B e-antigen-negative patients
    Thompson, A. J.
    Jackson, K.
    Hall, S.
    Hume, S.
    Burns, G.
    Mooney, B.
    Millen, R.
    Morris, R.
    Vogrin, S.
    Sundararajan, V.
    Ratnam, D.
    Levy, M.
    Lubel, J.
    Nicoll, A.
    Strasser, S.
    Sievert, W.
    Desmond, P.
    Ngu, M.
    Angus, P.
    Sinclair, M.
    Meredith, C.
    Matthews, G.
    Revill, P.
    Littlejohn, M.
    Bonanzinga, S.
    Bowden, D. S.
    Locarnini, S.
    Canchola, J.
    Siew, P.
    Lau, J.
    La Brot, B.
    Kuchta, A.
    Visvanathan, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 49 - 49
  • [40] Nucleos(t)ide analogue therapy decreases the HBeAg loss rate in HBeAg positive chronic hepatitis B patients with hepatitis flare: a propensity score matching study
    Peng, Chien-Wei
    Jeng, Rachel Wen-Juei
    Chen, Yi-Cheng
    Chien, Rong-Nan
    Liaw, Yun-Fan
    JOURNAL OF HEPATOLOGY, 2020, 73 : S862 - S863
12345